Title
Eosinophil cationic protein : a new biomarker of coronary atherosclerosis
Author
Faculty/Department
Faculty of Medicine and Health Sciences
Publication type
article
Publication
Amsterdam ,
Subject
Human medicine
Source (journal)
Atherosclerosis. - Amsterdam
Volume/pages
200(2010) :2 , p. 606-611
ISSN
0021-9150
ISI
000280612700044
Carrier
E
Target language
English (eng)
Full text (Publishers DOI)
Abstract
Aims Coronary atherosclerosis is a chronic inflammatory disease, but different inflammatory biomarkers may reflect different phases of atherosclerotic plaque evolution. We aimed at assessing the role of eosinophil cationic protein (ECP), a sensitive marker of eosinophil activation, and C-reactive protein (CRP) in coronary artery disease (CAD). Methods and results Consecutive anginal patients with angiographic evidence of CAD [stable angina (SA) or non-ST-elevation acute coronary syndrome (NSTE-ACS)], or with angiographically normal coronary arteries (NCA) were enrolled. The severity of CAD was graded according to Bogaty's score and coronary lesion morphology was defined as smooth or complex. Baseline ECP and high sensitivity CRP were measured in all patients. Of 198 patients (64 ± 10 years, male 74%), 91 had SA, 57 had NSTE-ACS and 50 had NCA. ECP levels were significantly higher in SA [30 μg/L (13.846.9), p < 0.001] and NSTE-ACS [21.8 μg/L (5.546.3), p = 0.016] compared to NCA [9.7 μg/L (6.113.6)], without significant difference between SA and NSTE-ACS (p = 0.45). CRP levels were significantly higher in NSTE-ACS [2.38 mg/L (1.1111.94)] compared to SA [1.48 mg/L (0.822.83), p = 0.03], and NCA [1.09 mg/L (0.82.1), p < 0.001], without significant difference between SA and NCA (p = 0.20). The addition of ECP to main cardiovascular risk factors improved the area under the curve from 0.88 to 0.92, p = 0.007 for the angiographic diagnosis of CAD; further addition of CRP increased the area to 0.94, p = 0.014. At multiple linear regression analysis ECP levels independently predicted CAD severity (p = 0.001), whereas CRP levels independently predicted lesion complexity (p = 0.01). Conclusions Our study shows that ECP is a marker of CAD and that different inflammatory biomarkers reflect different phases of atherosclerotic plaque evolution.
E-info
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000280612700044&DestLinkType=RelatedRecords&DestApp=ALL_WOS&UsrCustomerID=ef845e08c439e550330acc77c7d2d848
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000280612700044&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=ef845e08c439e550330acc77c7d2d848
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000280612700044&DestLinkType=CitingArticles&DestApp=ALL_WOS&UsrCustomerID=ef845e08c439e550330acc77c7d2d848